Wolfgang P. Fendler
Papers
2
Total Citations
11
H-Index
2
About
Wolfgang P. Fendler is a leading researcher in nuclear medicine and molecular imaging, whose work has significantly advanced the field of prostate cancer management. His primary research areas focus on the clinical application of prostate-specific membrane antigen (PSMA) PET/CT for staging, risk stratification, and intraoperative guidance. Dr. Fendler’s major contributions include pioneering the use of PSMA-based Cerenkov Luminescence Imaging (CLI) during robot-assisted radical prostatectomy, a technique that enhances the real-time detection of surgical margins to improve oncological outcomes. His influential 2021 paper on radiation protection and occupational exposure in this procedure has garnered 8 citations, underscoring its practical importance. More recently, his 2025 study on PSMA PET/CT-based local staging demonstrated its prognostic value in predicting biochemical recurrence after surgery, with 3 citations already reflecting its emerging impact. Dr. Fendler’s work bridges cutting-edge imaging technology and clinical practice, offering new tools for personalized treatment in prostate cancer. His achievements highlight a career dedicated to translating molecular imaging innovations into tangible benefits for patients and surgeons alike.
Research Focus
Key Achievements
Top Papers
- 1
- 2